About SienaQuant ™

SienaQuant™ is a SISCAPA Holdings Company, built on the foundation of proven science, trusted partnerships, and a leadership team with a decades-long track record in advancing proteomics technologies. SienaQuant™ brings together scientific rigor and operational excellence to deliver ultra-sensitive, targeted protein quantification solutions for research, diagnostics, and drug development.

With the same team that pioneered immuno-enrichment coupled to mass spectrometry (SISCAPA), we are now unlocking a new era in biology—one where proteins can be measured with single-molecule-level sensitivity and unparalleled precision. By pushing the boundaries of what’s measurable, SienaQuant™ is enabling the accurate quantification of previously undetectable biomarkers, transforming how we understand, monitor, and treat human disease.